Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
552 hedge funds and large institutions have $24.9B invested in Allergan plc in 2013 Q4 according to their latest regulatory filings, with 156 funds opening new positions, 215 increasing their positions, 150 reducing their positions, and 79 closing their positions.
110% more call options, than puts
Call options by funds: $593M | Put options by funds: $283M
97% more first-time investments, than exits
New positions opened: 156 | Existing positions closed: 79
77% more funds holding in top 10
Funds holding in top 10: 30 → 53 (+23)
55% more capital invested
Capital invested by funds: $16.1B → $24.9B (+$8.79B)
43% more repeat investments, than reductions
Existing positions increased: 215 | Existing positions reduced: 150
15% more funds holding
Funds holding: 479 → 552 (+73)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$738M |
| 2 |
O
OppenheimerFunds
New York
|
+$390M |
| 3 |
Jennison Associates
New York
|
+$315M |
| 4 |
SC
Sculptor Capital
New York
|
+$244M |
| 5 |
Morgan Stanley
New York
|
+$243M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$129M |
| 2 |
Legal & General Group
London,
United Kingdom
|
-$80.6M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$68.9M |
| 4 |
HM
HealthCor Management
New York
|
-$54.4M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$49.6M |
AGN Hedge Fund Activity: Q4 2013 in Review
552 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2013, worth a combined $24.9B — up 55% from $16.1B a quarter earlier.
Buyers outnumbered sellers: 156 funds opened new AGN positions and 79 closed out — a net gain of 77 holders — while 215 added to existing stakes and 150 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $738M. The largest seller was Lord, Abbett & Co, cutting an estimated $129M.
- 552 institutional investors held Allergan plc (AGN) as of Q4 2013, up from 479 in Q3 2013.
- Funds reported $24.9B of Allergan plc stock for Q4 2013, up 55% quarter-over-quarter.
- 156 funds opened new Allergan plc positions in Q4 2013 and 79 closed out, a net change of +77 holders.
- The largest Allergan plc buyer in Q4 2013 was Fidelity Investments, an estimated $738M added.
- The largest Allergan plc seller in Q4 2013 was Lord, Abbett & Co, an estimated $129M sold.
Based on aggregated 13F filings for Q4 2013.